Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
The current price of ABT is $109.58 USD — it has increased by +0.26% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
What is Abbott Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abbott Laboratories stocks are traded under the ticker ABT.
Is Abbott Laboratories stock price growing?▼
ABT stock has risen by +0.67% compared to the previous week, the month change is a -11.83% fall, over the last year Abbott Laboratories has showed a -14.41% decrease.
What is Abbott Laboratories market cap?▼
Today Abbott Laboratories has the market capitalization of 190.55B
When is the next Abbott Laboratories earnings date?▼
Abbott Laboratories is going to release the next earnings report on April 22, 2026.
What were Abbott Laboratories earnings last quarter?▼
ABT earnings for the last quarter are 1.5 USD per share, whereas the estimation was 1.5 USD resulting in a +0.29% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abbott Laboratories revenue for the last year?▼
Abbott Laboratories revenue for the last year amounts to 83.9B USD.
What is Abbott Laboratories net income for the last year?▼
ABT net income for the last year is 26.8B USD.
Does Abbott Laboratories pay dividends?▼
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.59 USD. As of today, Dividend Yield (FWD)% is 2.31%.
How many employees does Abbott Laboratories have?▼
As of February 02, 2026, the company has 114,000 employees.
In which sector is Abbott Laboratories located?▼
Abbott Laboratories operates in the Health Care sector.
When did Abbott Laboratories complete a stock split?▼
The last stock split for Abbott Laboratories was on June 01, 1998 with a ratio of 2:1.
Where is Abbott Laboratories headquartered?▼
Abbott Laboratories is headquartered in North Chicago, US.